Functional and Quality of Life Improvement Following Transcatheter Heart Valve Implantation

NCT02023060 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-11-29

No results posted yet for this study

Summary

The objective is to observe trends in patient characteristics and outcomes after aortic or mitral transcatheter heart valve replacement over time.

Conditions

  • Trans Catheter Aortic Valve
  • Aortic Stenosis

Sponsors & Collaborators

  • Sheba Medical Center

    lead OTHER_GOV

Principal Investigators

  • Israel Barbash, MD · Sheba Medical Center, Tel Hashomer

Eligibility

Min Age
18 Years
Max Age
110 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2030-11-30
Completion
2030-11-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02023060 on ClinicalTrials.gov